BE-26263
BE-26263, an antiosteoporotic agent that can be isolated from Scedosporium apiospermum, possesses estrogenic effect[1].
Product Specifications
CAS Number
147716-81-2
UNSPSC
12352005
Target
Estrogen Receptor/ERR
Type
Natural Products
Related Pathways
Vitamin D Related/Nuclear Receptor
Applications
Metabolism-protein/nucleotide metabolism
Field of Research
Endocrinology; Metabolic Disease
Assay Protocol
https://www.medchemexpress.com/be-26263.html
Solubility
10 mM in DMSO
Smiles
OC1=C(C(OC(CC(OC(CC2=CC(O)=CC(O)=C2C3=O)C)=O)C)=O)C(CC(OC(CC(OC(CC(O3)C)=O)C)=O)C)=CC(O)=C1
Molecular Formula
C32H38O14
Molecular Weight
646.64
References & Citations
[1]Jpn Kokai Tokkyo Koho, et al. Estrogenic BE-26263 and its manufacture with Scedosporium apiospermum. Patent JP 05032658.|[2]Rakesh Maurya, et al. Antiosteoporotic Agents From Natural Sources. Studies in Natural Products Chemistry Volume 35, 2008, Pages 517-548.
Shipping Conditions
Room temperature
Scientific Category
Natural Products
Clinical Information
No Development Reported
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog